Aurora, a Global Leader in Medical Cannabis, Announces Results of 2026 Annual General Meeting

EDMONTON, AB, Aug. 10, 2026 /PRNewswire/ -- Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) ("Aurora" or the "Company"), the Canadian-based leading global medical cannabis company, is pleased to announce the voting results from its Annual General Meeting of Shareholders (the "Meeting") held Friday August 7, 2026 by virtual webcast. The total number of shares represented by shareholders present in person (virtually) and by proxy at the Meeting was 16,639,306 common shares, representing 26.86% of Aurora's issued and outstanding common shares as of the record date.

PRNewsWire • a day ago

Aurora Cannabis Shareholders Approve Board as Fiscal 2026 Results Beat Outlook

Aurora Cannabis NASDAQ: ACB said shareholders approved all items presented at its annual general meeting, including setting the board size at five directors, electing the company's nominees, reappointing Ernst & Young LLP as auditor, and approving its non-binding advisory vote on executive compensation.

MarketBeat • Aug 7, 2026

Aurora Cannabis Inc. (ACB:CA) Shareholder/Analyst Call Transcript

Aurora Cannabis Inc. (ACB:CA) Shareholder/Analyst Call Transcript

Seeking Alpha • Aug 7, 2026

Aurora Cannabis Q1 Earnings Call Highlights

Aurora Cannabis NASDAQ: ACB reported fiscal first-quarter 2027 net revenue of C$67.6 million, as growth in international medical cannabis sales was offset by lower Canadian medical revenue following reimbursement changes and the company's planned exit from lower-margin Canadian consumer cannabis operations.

MarketBeat • Aug 5, 2026

Aurora Cannabis Inc. (ACB:CA) Q1 2027 Earnings Call Transcript

Aurora Cannabis Inc. (ACB:CA) Q1 2027 Earnings Call Transcript

Seeking Alpha • Aug 5, 2026

Aurora Cannabis Announces Fiscal 2027 First Quarter Results

NASDAQ | TSX: ACB Delivers Net Revenue of $67.6 million, including a 17% YoY Increase in International Medical Cannabis Net Revenue Safari Flower Company Receives Three-Year EU-GMP Certification, Strengthens Ability to Supply Growing, High-Margin International Medical Cannabis Markets Maintains Strong Balance Sheet with $149.1 million of Cash, Cash Equivalents 2 and Short-Term Investments with no Debt EDMONTON, AB, Aug. 5, 2026 /PRNewswire/ -- Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the first quarter 2027 ending June 30, 2026. "We remain confident in our commercial execution, supported by our genetics program and regulatory and operational expertise which underpin our leadership in Canada, Germany, Poland, Australia, and New Zealand.

PRNewsWire • Aug 5, 2026

Aurora Cannabis Inc. (ACB) Q1 Earnings and Revenues Beat Estimates

Aurora Cannabis Inc. (ACB) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of a loss of $0.13 per share. This compares to a loss of $0.19 per share a year ago.

Zacks Investment Research • Aug 5, 2026

3 Canadian Marijuana Stocks Can Make You Big Gains

Most marijuana stocks, when they trade well, are driven by certain factors. Now there is no official, set way to determine what constitutes better trading. Yet history has shown that some variables can play big factors across the board.

Aurora Receives Support from Leading Independent Proxy Adviser Institutional Shareholder Services Inc. for the 2026 Annual General Meeting of Shareholders

ISS has recommended that Aurora's shareholders vote FOR all director nominees and meeting resolutions Shareholders are encouraged to vote early in favour of all resolutions – every vote matters, no matter how many shares you own Shareholders who have questions or need assistance with voting their shares should contact Aurora's strategic advisor and proxy solicitation agent, Kingsdale Advisors, by telephone at 1-800-749-9052 or by email at   [email protected]  or visit  www.MyAuroraVote.com EDMONTON, AB, July 27, 2026 /PRNewswire/ -- Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) ("Aurora" or the "Company"), the Canadian-based leading global medical cannabis company, is pleased to announce that  Institutional Shareholder Services Inc. (ISS), the leading independent proxy advisory firm whose voting recommendations are widely relied upon by major institutional investors, has recommended that Aurora's shareholders vote FOR all resolutions set forth in the Company's management information circular (the "Circular") in advance of its upcoming Annual General Meeting of Shareholders. The Circular is available on the Company's website and under Aurora's profile on SEDAR+.

PRNewsWire • Jul 27, 2026

Safari Flower Company, a Wholly Owned Subsidiary of Aurora Cannabis, Receives EU-GMP Certification at Niagara Facility

The achievement strengthens Safari's ability to serve international medical cannabis markets under the strictest regulations EDMONTON, AB, July 23, 2026 /PRNewswire/ -- Safari Flower Company ("Safari"), a wholly owned subsidiary of Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), is proud to announce the receipt of European Union Good Manufacturing Practice ("EU-GMP") certification for its Ontario facility, solidifying its ability to serve international medical cannabis markets. The certification is granted for a three-year term and validates Safari Flower Company's unwavering commitment to meeting the highest international standards for quality, compliance and operational excellence.

PRNewsWire • Jul 23, 2026